| __timestamp | Eli Lilly and Company | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 6620800000 | 79529000 |
| Thursday, January 1, 2015 | 6533000000 | 91224000 |
| Friday, January 1, 2016 | 6452000000 | 102413000 |
| Sunday, January 1, 2017 | 6588100000 | 146987000 |
| Monday, January 1, 2018 | 5975100000 | 213695000 |
| Tuesday, January 1, 2019 | 6213800000 | 342000000 |
| Wednesday, January 1, 2020 | 6121200000 | 661000000 |
| Friday, January 1, 2021 | 6431600000 | 1283000000 |
| Saturday, January 1, 2022 | 6440400000 | 2676000000 |
| Sunday, January 1, 2023 | 6941200000 | 3297000000 |
| Monday, January 1, 2024 | 8593800000 | 3790000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding the financial strategies of leading companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Eli Lilly and Company and Genmab A/S from 2014 to 2023. Over this period, Eli Lilly consistently allocated a significant portion of its budget to SG&A, with expenses peaking in 2023 at approximately 7% higher than in 2014. In contrast, Genmab A/S exhibited a remarkable growth trajectory, with SG&A expenses surging by over 4,000% during the same period. This stark difference highlights Eli Lilly's steady approach compared to Genmab's aggressive expansion strategy. As the pharmaceutical landscape continues to shift, these trends offer valuable insights into how these companies prioritize operational and marketing expenditures to maintain their competitive edge.
Who Optimizes SG&A Costs Better? Eli Lilly and Company or Zoetis Inc.
Breaking Down SG&A Expenses: Eli Lilly and Company vs Amgen Inc.
Comparing SG&A Expenses: Eli Lilly and Company vs argenx SE Trends and Insights
Comparing SG&A Expenses: Eli Lilly and Company vs Halozyme Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Perrigo Company plc
Eli Lilly and Company and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Eli Lilly and Company or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and BioCryst Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Genmab A/S: SG&A Expense Trends
Genmab A/S vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Genmab A/S vs Travere Therapeutics, Inc.: SG&A Expense Trends